发明名称 Glycopegylated factor IX
摘要 Conjugates between Factor IX and PEG moieties. are disclosed in the present application. The conjugates are linked via a glycosyl linking group interposed between and covalently attached to the peptide and the modifying group. Conjugates are formed from glycosylated peptides by the action of a glycosyltransferase. The glycosyltransferase ligates a modified sugar moiety onto a glycosyl residue on the peptide. Also provided are methods for preparing the conjugates, methods for treating various disease conditions with the conjugates, and pharmaceutical formulations including the conjugates.
申请公布号 US8791070(B2) 申请公布日期 2014.07.29
申请号 US201314052442 申请日期 2013.10.11
申请人 Novo Nordisk A/S 发明人 DeFrees Shawn;Bayer Robert J.;Bowe Caryn;Paneerselvam Krishnasamy
分类号 A61K38/00;A61P7/00;C12N9/64 主分类号 A61K38/00
代理机构 代理人 Brignati Michael J.
主权项 1. A PEGylated Factor IX protein comprising SEQ ID NO:1 and a poly(ethylene glycol) moiety, wherein the poly(ethylene glycol) moiety is conjugated to an amino acid selected from Asn 157 and Asn 167 of SEQ ID NO:1 via a glycosyl linking group of a glycosyl residue, and having a composition according to the formula: wherein R2 is COOH;R3 is H;R4 is OH;D is OH; andG is R1-L- wherein L is C(O)CH2NHC(O); andR1 is the poly(ethylene glycol) moiety, wherein the poly(ethylene glycol) moiety comprises a branched poly(ethylene glycol) having a core glycerol moiety, and wherein the branched poly(ethylene glycol) has a molecular weight of about 40 kDa.
地址 Bagsvaerd DK